GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY

GNIPST BULLETIN 2017 31 st March, 2017 Volume No.: 65 Issue No.: 03 Vision To develop responsible citizens who would be professionally equipped to think globally and act locally and become reformers of society to meet the challenges of future. Mission To impart high quality pharmaceutical science, technology and management education to the budding professionals and provide the ambience needed for developing requisite skills to make a mark of excellence in Education, Research, Business, Industry and achieve highest personal standards. Contents Message from PRINCIPAL Editorial board Historical article News Update Knowledge based Article Disease Related Breaking News Upcoming Events Drugs Update Campus News Student s Section Editor s Note Archive GNIPST Photo Gallery For your comments/contribution OR For Back-Issues, mailto:gnipstbulletin@gmail.com GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY W e bs i t e : ht t p: / / gni ps t. a c. i n

MESSAGE FROM PRINCIPAL "It can happen. It does happen. But it can't happen if you quit." Lauren Dane. We are what we repeatedly do. Excellence then is not an act, but a habit. Aristotle It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the last year s editors and congratulate the newly selected editors for the current year. Our first consideration is always in the best interest of the students. Our goal is to promote academic excellence and continuous improvement. I believe that excellence in education is aided by creating a learning environment in which all learners are supported in maximizing their potential and talents. Education needs to focus on personalized learning and instruction, while promoting an education system that is impartial, universally accessible, and meeting the needs of all students. It is of paramount importance that our learners have sufficient motivation and encouragement in order to achieve their aims. We are all very proud of you, our students, and your accomplishments and look forward to watching as you put your mark on the profession in the years ahead. The call of the time is to progress, not merely to move ahead. Our progressive Management is looking forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in this direction and fruits of these efforts will be received by our students in the near future. Our Teachers are committed and dedicated for the development of the institution by imparting their knowledge and play the role of facilitator as well as role model to our students. The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic needs of our students. I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the opportunities and meet the challenges with purpose and determination. Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on this path. My best wishes to all. Dr. A. Sengupta 1

EDITORIAL BOARD CHIEF EDITOR DR. ABHIJIT SENGUPTA EDITOR MS. JEENATARA BEGUM ASSOCIATE EDITOR MR. DIPANJAN MANDAL HISTORICAL ARTICLE Thomas Alva Edison Thomas Alva Edison is one of the greatest American inventors who held countless patents, majority of them related to electricity and power. While two of his most famous inventions are the incandescent lamp and the phonograph, arguably the most significant invention of Edison is considered to be organized research. Early Life: Edison was born on February 11, 1847 in the historic city of Milan (Ohio). His father was a versatile person and a man-of-all-work, while his mother was a teacher. Edison was mostly homeschooled by his mother. Edison became a salesman of fruit, paper and other goods on the Grand Trunk Railroad at a tender age of 12. With the help of his tiny handpress in a trash car, he wrote and published the Grand Trunk Herald in 1862, which was sent to 400 railroad employees. The same year Edison worked as a telegraph operator, trained by the father of a kid whose life he had saved. Edison was a tramp telegrapher, as he was exempted from military service due to his deafness. He was recruited in 1868 by Western Union Telegraph Company in Boston. Early Conceptions: Perhaps the first invention of Edison was a telegraph repeater in 1864 which worked automatically, while his earliest patent was registered for an electric vote recorder. He acquired partnership in a New York electrical company in 1869, where he honed the stock ticker and sold it. With all his money, Edison paid for his own 2

factory in Newark, N.J., where he hired technicians to help him with the inventions. His dream was to create an invention factory. Almost 80 earnest men, including physicists, mathematicians and chemists, were among his collaborators. Invention to order made him good money at this place. From 1870 to 1875 Edison devised many telegraphic advances including receivers, transmitters, the duplex, tape and automatic printers. He also collaborated in 1871 with Christopher Sholes, also known as father of the typewriter, to ameliorate the typing machine. Edison claimed to have made twelve typewriters at Newark in 1870. As a result, the Remington Company purchased his interests. Edison s carbon telegraph transmitter for Western Union brought a breakthrough for the creation of the Bell telephone. The money he got from Western Union for the transmitter was spent to establish a factory in Menlo Park, N.J. One more time, he used scientific talent to register over 300 patents in only 6 years. His electric pen (1877) developed stencils to produce copies. Other Inventions and Contributions: Probably his most impressive invention, the phonograph, was patented in 1877. By 1890 Edison had about 80 patents under his name, and that was pretty much the reason The Victor Company came into being. To explore incandescence, Edison and his fellows, among them J. P. Morgan, developed the Edison Electric Light Company in 1878. Years later, the company became the General Electric Company. Edison invented the first practical incandescent lamp in 1879. With months of hard work researching metal filaments, Edison and his staff analyzed 6,000 organic fibers around the world and determined that the Japanese bamboo was ideal for mass production. Large scale production of these cheap lamps turned out to be profitable, hence the first fluorescent lamp was patented in 1896. Edison made an amazing discovery in pure science, termed as the Edison Effect. He discovered in 1883 that electrons flowed from 3

incandescent filaments. The lamp could function as a valve using a metal-plate insert, while taking only negative electricity. A method to transmit telegraphic aerial signals over short distances was patented by Edison in 1885. The wireless patent was later sold to Guglielmo Marconi. The huge West Orange, N.J., factory was supervised from 1887 to 1931 by Edison. This was probably the world s most cutting-edge research laboratory, and a forerunner to modern research and development laboratories, with experts systematically investigating and researching for the solution of problems. The Edison battery, made perfect in 1910, used an alkaline electrolyte, and proved to be a superb storage device. The copper oxide battery, strikingly similar to modern dry cells, was modified in 1902. The kinetograph, his motion picture camera, was able to photograph action on 50-foot strips of film, and produced about sixteen images per foot. A young assistant of Edison built a small laboratory in 1893 called the Black Maria, which was substantial in making the first Edison movies. The kinetoscope projector of 1893 finally displayed the films. The earliest commercial movie theater, a peepshow, was established in New York in 1884. After developing and modifying the projector of Thomas Armat in 1895, Edison commercialized it as the Vitascope. The Edison Company created over 1,700 movies. Edison set the benchmark for talking pictures in 1904 by synchronizing movies with the phonograph. His cinemaphone adjusted the film speed to phonograph speed. The kinetophone projected talking pictures in 1913. The phonograph, behind the screen, was synchronized by pulleys and ropes with the projector. Edison brought forth many talkies. The universal motor, which utilized alternating or direct current, appeared in 1907. The electric safety lantern, patented in 1914, significantly reduced casualties among miners. The same year Edison devised the telescribe, which unified characteristics of the telephone and dictating phonograph. 4

Services for the Government: Edison presided the U.S. Navy Consulting Board throughout World War I and made 45 more inventions. These inventions included substitutes for antecedently imported chemicals (such as carbolic acid), a ship-telephone system, an underwater searchlight, defensive instruments against U-boats, among others. Later on, Edison launched the Naval Research Laboratory, the eminent American institution for research involving organized weapons. Death: This multi-genius died on Oct. 18, 1931 in West Orange, N.J. The laboratory buildings and equipment affiliated with Edison were upheld in Greenfield Village, Detroit, Michigan by Henry Ford, a friend and admirer. NEWS UPDATE Preclinical research: More reliably predicting what will work: (31 st March, 2017) A recent study has shown that a more flexible approach to study design can significantly improve the efficiency of preclinical research. Genes associated with Erdheim-Chester disease also linked to cancer: (31 st March, 2017) Newly identified genes associated with Erdheim-Chester disease (ECD), an ultra-rare disease, are also linked to cancer, according to a new study. Thus, ECD should be considered a type of cancer and treated by oncologists. A new clinical trial -- enrolling ECD patients now -- will test the use of the drugs dabrafenib and trametinib. Experimental small molecule shows potential in preventing meth relapse: (31 st March, 2017) The reason methamphetamine users find it so hard to quit -- 88 percent of them relapse, even after rehab -- is that meth takes advantage of the brain's natural learning process, say scientists. 5

Helping the retina regenerate: (31 st March, 2017) A new report gives recommendations for regenerating retinal ganglion cells (RGCs), crucial neurons in the back of the eye that carry visual information to the brain. Children with autism find understanding facial expressions difficult but make similar mistakes as peers, new study finds: (31 st March, 2017) Young people with autism spectrum conditions (ASC) have difficulties recognizing and distinguishing between different facial expressions, according to research from one of the largest studies to look at emotion recognition in children and adolescents with ASC. A new approach to amplifying DNA: (31 st March, 2017) Analyzing DNA is useful for a number of vital applications. This includes diagnosis and monitoring of diseases, identification of criminals, and studying the function of a targeted segment of DNA. However, methods used for analyses often require more DNA than may be available in a typical sample. A new polymerase chain reaction method could help the amplification process, and thus develop robust assays that previously would not have been possible. For detail mail to editor KNOWLEDGE BASED ARTICLE FDA approves new eczema drug Dupixent The U.S. Food and Drug Administration approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or 6

those for whom topical therapies are not advisable. Dupixent can be used with or without topical corticosteroids. FDA s approval of Dupixent demonstrates our commitment to approving new and innovative therapies for patients with skin disease, said Julie Beitz, M.D., director of the Office of Drug Evaluation III in the FDA s Center for Drug Evaluation and Research. Eczema can cause significant skin irritation and discomfort for patients, so it is important to have a variety of treatment options available to patients, including those patients whose disease is not controlled by topical therapies. Atopic dermatitis, a chronic inflammatory skin disease, is often referred to as eczema, which is a general term for several types of inflammation of the skin. Atopic dermatitis is the most common of the many types of eczema; onset typically begins in childhood and can last through adulthood. The cause of atopic dermatitis is a combination of genetic, immune and environmental factors. In atopic dermatitis, the skin develops red, scaly and crusted bumps, which are extremely itchy. Scratching leads to swelling, cracking, weeping clear fluid, and finally, coarsening and thickening of the skin. Dupixent is administered as an injection under the skin. Dupixent s active ingredient is an antibody (dupilumab) that binds to a protein [interleukin-4 (IL-4) receptor alpha subunit (IL- 4Ra)], that causes inflammation. By binding to this protein, Dupixent is able to inhibit the inflammatory response that plays a role in the development of atopic dermatitis. The safety and efficacy of Dupixent were established in three placebo-controlled clinical trials with a total of 2,119 adult participants with moderate-to-severe atopic dermatitis not adequately controlled by topical medication(s). Overall, participants who received Dupixent achieved greater response, defined as clear or almost clear skin, and experienced a reduction in itch after 16 weeks of treatment. Dupixent can cause side effects such as serious allergic reactions and eye problems, such as pink eye (conjunctivitis) and 7

inflammation of the cornea (keratitis). If patients experience new or worsening eye symptoms such as redness, itching, pain or visual changes, they should consult a health care provider. The most common side effects include injection site reactions; cold sores in the mouth or on the lips; and eye and eyelid inflammation, including redness, swelling and itching. The safety and efficacy of Dupixent have not been established in the treatment of asthma. Patients who also have asthma should not adjust or stop their asthma treatment without talking to their physicians. The FDA granted the approval of Dupixent to Regeneron Pharmaceuticals, Inc. The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The Agency also is responsible for the safety and security of our nation s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. Jeenatara Begum Assistant Professor GNIPST DISEASE RELATED BREAKING NEWS Yellow fever Suriname: (28 th March, 2017) On 9 March 2017, the National Institute for Public Health and the Environment (RIVM) in the Netherlands reported a case of yellow fever to WHO. The patient is a Dutch adult female traveller who visited Suriname from the middle of February until early March 2017. She was not vaccinated against yellow fever. The case was confirmed for yellow fever in the Netherlands by RT- PCR in two serum samples taken with an interval of three days at the Erasmus University Medical Center (Erasmus MC), Rotterdam. The presence of yellow fever virus was confirmed on 9 8

March 2017 by PCR and sequencing at Erasmus MC, and by PCR on a different target at the Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. While in Suriname, the patient spent nights in Paramaribo and visited places around Paramaribo, including the districts of Commewijne (Frederiksdorp and Peperpot) and Brokopondo (Brownsberg), the latter is considered to be the most probable place of infection. She experienced onset of symptoms (headache and high fever) on 28 February 2017 and was admitted to an intensive care unit (University Medical Center) in the Netherlands on 3 March 2017 with liver failure. The patient is currently in critical condition. Suriname is considered an area at risk for yellow fever and requires a yellow fever vaccination certificate at entry for travellers over one year of age arriving from countries with risk of yellow fever, according to the WHO list of countries with risk of yellow fever transmission; WHO also recommends yellow fever vaccination to all travellers aged nine months and older. This is the first reported case of yellow fever in Suriname since 1972. Read more UPCOMING EVENTS International conference of Pharmacy (ICP-2017) organized by School of Pharmaceutical Sciences, Lovely Professional Univwersity, Punjab in collaboration with Society of Pharmaceutical Education and Research (SPER) will be held on 7 th to 8 th April, 2017. ICMR sponsored 10 th Annual Conference on Clinical Pharmacology for Health Ageing will be held in Mumbai on 28 th April to 1 st May, 2017. 9

DRUGS UPDATES FDA Approves Ocrevus: (28 th March, 2017) The U.S. Food and Drug Administration (FDA) has approved Ocrevus (ocrelizumab), a humanized monoclonal antibody designed to selectively target CD20-positive B cells as the first and only medicine for both relapsing and primary progressive forms of multiple sclerosis. Read more CAMPUS NEWS IRIS 2017: GNIPST is going to organize the cultural fest IRIS 2017 on 5 th and 6 th April, 2017. ICMR Sponsored National Seminar at Orisa: Congratulations to Ranit Kundu who have got first prize in oral presentation in ICMR sponsored National Seminar at Orissa. Intra college cricket tournament 2017: On 21 st and 22 nd February 2017 GNIPST organized Intra college cricket tournament. Congratulations to the winner: B.Pharm 2 nd year Man of the match: Soham Ray Highest wicket Taker: Shovon Ghosh Highest run scorer: Saikat Bera 10

Sardar Jodh Singh Trophy 2017: On 17 th February 2017 GNIPST participated in Sardar Jodh Singn Trophy 2017 and played the cricket match against Asansol Engineering College and GNIT. Annual Sports Meet 2017: On 14 th and 15 th February 2017 GNIPST organized Annual Sports Meet 2017. Congratulations to the following winner: Flat Race 100 m for Boys: 1 st : Suman Ghosh 2 nd : Arijit Mitra Thakur 3 rd : Arnab Ghosh Flat Race 100 m for Girls: 1 st : Moutan Roy 2 nd : Manpreet Kaur 3 rd : Kriti Prasad Flat Race 200 m for Boys: 1 st : Suman Ghosh 2 nd : Arnab Ghosh 3 rd : Abhiraj Pathak Flat Race 200 m for Girls: 1 st : Anjali Mondal 2 nd : Moutan Roy 3 rd : Kriti Prasad 3 Legged Race: 1 st : Aindrila Bhowmick Anjali Mondal 2 nd : Poulami Sarkar Pamolita Paul 3 rd : Renu Sha 11

Sayani Das Long Jump for Boys: 1 st : Abu Sufian 2 nd : Saikat Bera 3 rd : Arijit Mitra Thakur Long Jump for Girls: 1 st : Sayani Das 2 nd : Aindrila Bhowmick 3 rd : Anjali Mondal Skipping for Girls: 1 st : Moutan Roy 2 nd : Aindrila Bhowmick 3 rd : Anjali Mondal Shot put for Boys: 1 st : Arijit Mitra Thakur 2 nd : Bishal Kr. Singh 3 rd : Abu Sufian Shot put for Girls: 1 st : Koyel Ghosh 2 nd : Aindrila Bhowmick 3 rd : Pamolita Paul Discuss throw for Boys: 1 st : Arijit Mitra Thakur 2 nd : Monojit Dutta 3 rd : Bishal Kr. Singh Discuss throw for Girls: 1 st : Nasrina Mondal 2 nd : Aparupa Sinha 3 rd : Kriti Prasad Sack Race 50 m for Boys: 1 st : Sneham Sen 12

2 nd : Arijit Mitra Thakur 3 rd : Maruf Billa Akunji Sack Race 50 m for Girls: 1 st : Kriti Prasad 2 nd : Nasrina Mondal 3 rd : Moutan Roy Relay Race (4x100 m) for Boys: Winner: Sneham Sen Abhiraj Pathak Arijit Mitra Thakur Suman Ghosh Relay Race (4x100 m) for Girls: Winner: Kriti Prasad Sayani Das Nasima Mondal Sunanda Konar Go for Goal for Boys: 1 st : Abhiraj Pathak 2 nd : Arnab Ghosh 3 rd : Subhankar Malakar Balance Race 100 m for Girls: 1 st : Aindrila Bhowmick 2 nd : Pamolita Paul 3 rd : Moutan Roy Tug of War (Boys): Winner: Arnab Mondal Arnab Chakrabarty Asif Iqbal Ankit Chowdhury Arnab Sarkar Tug of War (Girls): 13

Winner: Aparupa Sinha Priya Bardhan Roy Poulami Sarkar Pamolita Paul Moutan Roy Flat Race for /male Staff: 1 st : Dr. Subhendu Bandyopadhyay 2 nd : Debabrata Ghosh Dastidar 3 rd : Dipanjan Mondal Hit the Stamp for Male Staff: 1 st : Dipanjan Mondal 2 nd : Debabrata Ghosh Dastidar 3 rd : Dr. Asis Bala Hit the Stamp for Female Staff: 1 st : Anuranjita Kundu 2 nd : Prapti Chakraborty 3 rd : Rakhi Balance Race for Female Staff: 1 st : Moumita Chowdhury 2 nd : Priyanka Ray 3 rd : Jeenatara Begum Hari Bhanga for Female Staff: 1 st : Sumana Roy 2 nd : Priyanka Ray 3 rd : Rakhi Tug of War (Female Staff): Winner: Dr. Sumana Chatterjee Dr. Sriparna Kundu Sen Sumana Roy Jeenatara Begum Moumita Chowdhury 14

Jaya Banerjee Satabdi Sunknowledge Pvt. Ltd.: Cngratulations to the students who got the job of Sonknowledge Pvt. Ltd. 1. Aishwarya Datta 2. Debjani Saha 3. Sayani Banerjee 4. Priya Dey 5. Anurag T K Baidya 6. Diptarco Singha 7. Soumyadeep Bhattachrya 8. Soumava Bhattacharya 9. Aniruddha Bhar 10. Dibyojyoti Chatterjee QUIZ organized by GNIDSR: Congratulations to Pratik Nandi and Bhaskar, who have acquired 2 nd position in quiz competition organized by GNIDSR. Reminiscence 2017: On 12 th February, 2017 GNIPST celebrated Reunion programme. GPAT 2017: The following B.Pharm. final year students have qualified, GPAT- 2017. We congratulate them all. Anjali Mondal Anurag T K Baidya Arpita Ghosal Rudradip Das Swati Abat Tanaya Palit Tanmoy Saha 15

Cognizant: Congratulations to the students who got the job of Cognizant.. NBA Accreditation: NBA has accreditated GNIPST. Debate competition: On 19 th November, 2016 our student Pratik Nandy and Dippoman Guha was participated in All India University debate Competition organized by Calcutta Debate Circle. International seminar 2016: International seminar on Global Advancement in Pharmaceutical research and startup organized by GNIPST in collaboration with IPGA was held on 22 nd October, 2016 at GNIPST auditorium. NBA visit: The experts of National Board of Accreditation or NBA will be going to visit GNIPST on 24 th September and 25 th September, 2016. Freshers welcome programme: On 12 th September GNIPST organized the Freshers welcome programme Kulrav 2k16. GNIPST Football Match 2016: On 31 st August and 1 st September GNIPST sports club organized a football match. The winner of the football match was B.Pharm 3 rd year. Recent Trends in Pharmaceutical Research: A Science Awareness Programme comprising of seminar on Recent Trends in Pharmaceutical Research was organized by GNIPST in collaboration with National Academy of Science India (NASI) on 30 th august, 2016 from 2 pm to 4.30 pm at GNIPST auditorium. Plantation programme was also organized by Eco club. Dr. Hemanta Kumar Majumder, gave his valuable lecture on 16

Modern Biology & its Evolution and Dr. Pijush K Das delivered his lecture on Site specific Drug Targeting Magic Bullet approach. World Photography Day celebration: On 19 th August 2016 GNIPST celebrated World Photography Day at Dakhineswar. Friendly Football Match: On 15 th August 2016 GNIPST organised a friendly football match with Alumni members. Farewell 2016: On 25 th May 2016 GNIPST celebrated the farewell programme for the final year students. Best of luck to all final year students for their future life. ALUMNI MEMBERS 2016: Congratulations to new Alumni Members of GNIPST. Placement Record 2016: SL NO COMPANY NAME NUMBER OF STUDENT APPEARED/APPLIED NUMBER OF STUDENT SELECTED JOB PROFILE 1 DR. LAL PATH LAB 64 7 Sales, Marketing and office assistant 2 APOLLO PHARMACY 36 25 Hospital and retail chain pharmacist 3 ABBOTT INDIA 74 03 Sales and Marketing 4 HETERO DRUGS 18 18 (Waiting for final interview) Production, QC and QA 5 ERIS LIFE SCIENCES 01 01 (Joined) Sales and Marketing 6 JUPITER PHARMACEUTICALS 05 01 (Joined) Production, QC and QA 17

7 GOVT PHARMACIST 4 4 (Joined) Hospital Pharmacist 8 ALCHEMIST EYE HOSPITAL 9 OPTIVAL HEALTH SOLUTIONS PVT. LTD. (MEDPLUS) 2 2 (Waiting for final interview) Hospital Pharmacist 21 21 Community Pharmacist 10 NESTLE INDIA LTD 08 02 Nutrition Officer Trainee 11 LUPIN 01 01 Sales and Marketing 12 GSK PHARMACEUTICAL LTD 13 OAK PHARMACEUTICAL 05 02 (1 of them already joined) Sales and Marketing 06 02 (Joined) Sales and Marketing IPA Bengal Pharma & Healthcare trust scholarship 2016: Congratulations to Rudradip Das, student of B.Pharm 3 rd year has been awarded IPA Bengal Pharma & Healthcare trust scholarship 2016. Accreditation by NAAC: SL. NAME OF NO. THE INSTITUTE 01 Guru Nanak Institute of Pharmaceutical Science And Technology, Kolkata-700114 STATE West Bengal CGPA(out of scale 4) 2.70 B GRADE 18

GPAT 2016 Result: The following B.Pharm. final year students have qualified, GPAT- 2016. We congratulate them all. Aishika Datta Mainak Chatterjee Indira Saha Priyanka De Aheli Mukherjee Soumya Guha Debanjana Das Debalina Datta Evana Patra Himadrija Chatterjee IRIS 2016: GNIPST organized colllege fest IRIS 2016 from 11 th to 13 th March, 2016. Result of different events: Intracollege Quiz competition: 1 st : Arani Roy and Dipayan Nath 2 nd : Bhaskar Singha and Pratik Nandi Intracollege Painting competition: 1 st : Swagata Paul 2 nd : Aviraj Pathak 3 rd : Dippyoman Guha Group Dance Competition: Karma Group Intercollege Solo Dance Competition: 1 st : Monodipa Ghosh 2 nd : Aditya Paul (NIT) Antaksari Competition: 1 st : Sunanda and Aparupa 19

2 nd : Meghna and Joyita 3 rd : Arpita and Pami Intercollege Solo Singing Competition: 1 st : Arpita Sarkar 2 nd : Arvind Raj (Sudhir Chandra College) 3 rd : Priyam Mondal (Supreme College) Intercollege Band Competition: 1 st : D Errors 2 nd : Mukti 3 rd : GNIPST band Fashion: Best Male: Md. Nadeem Shah Best Female: Sweta Best Couple: Md. Nadeem Shah and Susmita Kar Blood donation Camp 2016: On 4 th March 2016 Social Service club and Alumni Association of GNIPST organized a Blood donation camp in association with Association of voluntary Blood Donars, West Bengal. National Assessment and Accreditation Council (NAAC): A NAAC peer team completed a three-day inspection (17 th February to 19 th February, 2016) of GNIPST to evaluate its academic credibility and infrastructure on Friday. Saraswati Puja 2016: On 13 th February 2016 the students of GNIPST celebrated Saraswati Puja at GNIPST campus. 20

STUDENTS SECTION WHO CAN ANSWER FIRST???? Identify the person Answer of Previous Issue s Image: 20 th March Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students Section& answers of this Section at gnipstbulletin@gmail.com EDITOR S NOTE It is a great pleasure for me to publish the 3 rd issue of 65 th Volume of GNIPST BULLETIN. All the followers of GNIPST BULLETIN are able to avail the bulletin through facebook account GNIPST bulletin I am very much thankful to all the GNIPST members and readers who are giving their valuable comments, encouragements and supports. I am also thankful to Dr. Abhijit Sengupta, Director of GNIPST for his valuable advice and encouragement. Special thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar and Mr. Soumya Bhattacharya for their kind co-operation and technical supports. Thank you Mr. Soumya Bhattacharya for the questionnaires of the student section. An important part of the 21

improvement of the bulletin is the contribution of the readers. You are invited to send in your write ups, notes, critiques or any kind of contribution for the forthcoming special and regular issue. ARCHIVE OTHERS: AICTE has sanctioned a release of grant under Research Promotion Scheme (RPS) during the financial year 2012-13to GNIPST as per the details below: a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical Science & Technology. b. Principal Investigator: Dr. LopamudraDutta. c. Grant-in-aid sanctioned:rs. 16,25000/- only d. Approved duration: 3 years e. Title of the project: Screening and identification of potential medicinal plant of Purulia & Bankura districts of West Bengal with respect to diseases such as diabetes, rheumatism, Jaundice, hypertension and developing biotechnological tools for enhancing bioactive molecules in these plants. Activity Clubs of GNIPST: Name of Club Member Faculty CULTURAL Ms. Priyanka Ray DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya ECO Ms. Sumana Roy LITERARY AND PAINTING Ms. Jeenatara Begum PHOTOGRAPHY Ms. Sanchari Bhattacharya and Mr. Abir Koley SCIENCE AND INNOVATIVE Mr. Samrat Bose MODELLING SOCIAL SERVICES Dr. Asis Bala SPORTS Mr. Debabrata GhoshDastidar 22